GVP Auditor 31

Auditor Ph.D., is an accomplished professional with extensive experience in pharmacovigilance and drug safety. With a background in chemistry, he earned his Philosophical Doctorate from Tohoku University/Kyoto University in 1971. Dr. He has held key positions in various pharmaceutical companies, including Sankyo Co. Ltd., where he served as Director of Research Institute and held other leadership roles. His notable achievements include being an invited speaker at DIA Pharmacovigilance and Annual Meetings, as well as serving as a project manager for a global safety database. He has received several awards, including the FDA Recognition Award, and has been involved in international activities, such as translation and Toastmaster International. As an executive consultant, he has provided guidance to numerous pharmaceutical companies, both in Japan and internationally. Additionally, he has conducted PV audits for various pharmaceutical firms. His extensive expertise and contributions in the field of pharmacovigilance make him a distinguished figure in the industry.